IMMvention Therapeutix, Inc. is a biotech developing therapies modulating innate immunity pathways to treat unmet medical needs. The firm expertise lies in developing therapies to activate or inhibit innate immunity pathways that initiate responses to eliminate cancer, autoimmune and infectious diseases. Understanding of the innate immunity pathways is coupled with companys novel AceIMMune technology platform that specifically targets drugs only to immune cells to enable high specificity, efficacy and safety. With a limited SBIR footprint, IMMvention is developing its product pipeline for high-unmet diseases and partnering with large pharmaceutical companies to apply the AceIMMune technology to partners drug molecules rapidly to progress and establish clinical validation of the platfo
